Found 9 hits for monomerid = 244209 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Mitogen-activated protein kinase 1
(Homo sapiens (Human)) | BDBM244209
((s)-n-(2-(dimethylamino)-1-phenylethyl)-5,5-dimeth...)Show SMILES CN(C)CC(NC(=O)N1Cc2nc(Nc3ccccc3)ncc2C1(C)C)c1ccccc1 Show InChI InChI=1S/C25H30N6O/c1-25(2)20-15-26-23(27-19-13-9-6-10-14-19)28-22(20)17-31(25)24(32)29-21(16-30(3)4)18-11-7-5-8-12-18/h5-15,21H,16-17H2,1-4H3,(H,29,32)(H,26,27,28) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 448 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Novartis AG
US Patent
| Assay Description Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept... |
US Patent US9546173 (2017)
BindingDB Entry DOI: 10.7270/Q2GT5Q52 |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 1
(Homo sapiens (Human)) | BDBM244209
((s)-n-(2-(dimethylamino)-1-phenylethyl)-5,5-dimeth...)Show SMILES CN(C)CC(NC(=O)N1Cc2nc(Nc3ccccc3)ncc2C1(C)C)c1ccccc1 Show InChI InChI=1S/C25H30N6O/c1-25(2)20-15-26-23(27-19-13-9-6-10-14-19)28-22(20)17-31(25)24(32)29-21(16-30(3)4)18-11-7-5-8-12-18/h5-15,21H,16-17H2,1-4H3,(H,29,32)(H,26,27,28) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 1.25E+5 | n/a | n/a | n/a | n/a | 7.5 | n/a |
Novartis AG
US Patent
| Assay Description Compound potency against activated ERK2 was determined using a kinase assay that measures ERK2-catalyzed phosphorylation of biotinylated ERKtide pept... |
US Patent US9546173 (2017)
BindingDB Entry DOI: 10.7270/Q2GT5Q52 |
More data for this Ligand-Target Pair | |
Ribosomal protein S6 kinase alpha 1
(Homo sapiens (Human)) | BDBM244209
((s)-n-(2-(dimethylamino)-1-phenylethyl)-5,5-dimeth...)Show SMILES CN(C)CC(NC(=O)N1Cc2nc(Nc3ccccc3)ncc2C1(C)C)c1ccccc1 Show InChI InChI=1S/C25H30N6O/c1-25(2)20-15-26-23(27-19-13-9-6-10-14-19)28-22(20)17-31(25)24(32)29-21(16-30(3)4)18-11-7-5-8-12-18/h5-15,21H,16-17H2,1-4H3,(H,29,32)(H,26,27,28) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 94 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG
US Patent
| Assay Description Lists compounds that were tested for inhibition of RSK; the IC50 values are in micromolar units, and refer to inhibition of RSK1 and RSK2, respective... |
US Patent US9546173 (2017)
BindingDB Entry DOI: 10.7270/Q2GT5Q52 |
More data for this Ligand-Target Pair | |
Ribosomal protein S6 kinase alpha-3
(Homo sapiens (Human)) | BDBM244209
((s)-n-(2-(dimethylamino)-1-phenylethyl)-5,5-dimeth...)Show SMILES CN(C)CC(NC(=O)N1Cc2nc(Nc3ccccc3)ncc2C1(C)C)c1ccccc1 Show InChI InChI=1S/C25H30N6O/c1-25(2)20-15-26-23(27-19-13-9-6-10-14-19)28-22(20)17-31(25)24(32)29-21(16-30(3)4)18-11-7-5-8-12-18/h5-15,21H,16-17H2,1-4H3,(H,29,32)(H,26,27,28) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 96 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG
US Patent
| |
US Patent US9546173 (2017)
BindingDB Entry DOI: 10.7270/Q2GT5Q52 |
More data for this Ligand-Target Pair | |
Ribosomal protein S6 kinase alpha-3
(Homo sapiens (Human)) | BDBM244209
((s)-n-(2-(dimethylamino)-1-phenylethyl)-5,5-dimeth...)Show SMILES CN(C)CC(NC(=O)N1Cc2nc(Nc3ccccc3)ncc2C1(C)C)c1ccccc1 Show InChI InChI=1S/C25H30N6O/c1-25(2)20-15-26-23(27-19-13-9-6-10-14-19)28-22(20)17-31(25)24(32)29-21(16-30(3)4)18-11-7-5-8-12-18/h5-15,21H,16-17H2,1-4H3,(H,29,32)(H,26,27,28) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 2.02E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG
US Patent
| |
US Patent US9546173 (2017)
BindingDB Entry DOI: 10.7270/Q2GT5Q52 |
More data for this Ligand-Target Pair | |
Ribosomal protein S6 kinase alpha-3
(Homo sapiens (Human)) | BDBM244209
((s)-n-(2-(dimethylamino)-1-phenylethyl)-5,5-dimeth...)Show SMILES CN(C)CC(NC(=O)N1Cc2nc(Nc3ccccc3)ncc2C1(C)C)c1ccccc1 Show InChI InChI=1S/C25H30N6O/c1-25(2)20-15-26-23(27-19-13-9-6-10-14-19)28-22(20)17-31(25)24(32)29-21(16-30(3)4)18-11-7-5-8-12-18/h5-15,21H,16-17H2,1-4H3,(H,29,32)(H,26,27,28) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 461 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG
US Patent
| |
US Patent US9546173 (2017)
BindingDB Entry DOI: 10.7270/Q2GT5Q52 |
More data for this Ligand-Target Pair | |
Ribosomal protein S6 kinase alpha-3
(Homo sapiens (Human)) | BDBM244209
((s)-n-(2-(dimethylamino)-1-phenylethyl)-5,5-dimeth...)Show SMILES CN(C)CC(NC(=O)N1Cc2nc(Nc3ccccc3)ncc2C1(C)C)c1ccccc1 Show InChI InChI=1S/C25H30N6O/c1-25(2)20-15-26-23(27-19-13-9-6-10-14-19)28-22(20)17-31(25)24(32)29-21(16-30(3)4)18-11-7-5-8-12-18/h5-15,21H,16-17H2,1-4H3,(H,29,32)(H,26,27,28) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 112 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG
US Patent
| |
US Patent US9546173 (2017)
BindingDB Entry DOI: 10.7270/Q2GT5Q52 |
More data for this Ligand-Target Pair | |
Ribosomal protein S6 kinase alpha 1
(Homo sapiens (Human)) | BDBM244209
((s)-n-(2-(dimethylamino)-1-phenylethyl)-5,5-dimeth...)Show SMILES CN(C)CC(NC(=O)N1Cc2nc(Nc3ccccc3)ncc2C1(C)C)c1ccccc1 Show InChI InChI=1S/C25H30N6O/c1-25(2)20-15-26-23(27-19-13-9-6-10-14-19)28-22(20)17-31(25)24(32)29-21(16-30(3)4)18-11-7-5-8-12-18/h5-15,21H,16-17H2,1-4H3,(H,29,32)(H,26,27,28) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 1.77E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG
US Patent
| Assay Description Lists compounds that were tested for inhibition of RSK; the IC50 values are in micromolar units, and refer to inhibition of RSK1 and RSK2, respective... |
US Patent US9546173 (2017)
BindingDB Entry DOI: 10.7270/Q2GT5Q52 |
More data for this Ligand-Target Pair | |
Ribosomal protein S6 kinase alpha-3
(Homo sapiens (Human)) | BDBM244209
((s)-n-(2-(dimethylamino)-1-phenylethyl)-5,5-dimeth...)Show SMILES CN(C)CC(NC(=O)N1Cc2nc(Nc3ccccc3)ncc2C1(C)C)c1ccccc1 Show InChI InChI=1S/C25H30N6O/c1-25(2)20-15-26-23(27-19-13-9-6-10-14-19)28-22(20)17-31(25)24(32)29-21(16-30(3)4)18-11-7-5-8-12-18/h5-15,21H,16-17H2,1-4H3,(H,29,32)(H,26,27,28) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 86 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG
US Patent
| |
US Patent US9546173 (2017)
BindingDB Entry DOI: 10.7270/Q2GT5Q52 |
More data for this Ligand-Target Pair | |